136 related articles for article (PubMed ID: 31194608)
1. Collaborative Molecular Epidemiology Study of Metabolic Dysregulation, DNA Methylation, and Breast Cancer Risk Among Nigerian Women: MEND Study Objectives and Design.
Akinyemiju T; Salako O; Daramola A; Alatise O; Adeniyi A; Ogun G; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Ojo A; Tollefsbol T; Arnett D
J Glob Oncol; 2019 Jun; 5():1-9. PubMed ID: 31194608
[TBL] [Abstract][Full Text] [Related]
2. Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.
Akinyemiju T; Jones K; Gupta A; Oyekunle T; Saraiya V; Deveaux A; Salako O; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; ; Daramola A
BMC Cancer; 2021 Sep; 21(1):1051. PubMed ID: 34563146
[TBL] [Abstract][Full Text] [Related]
3. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.
Palmer JR; Ambrosone CB; Olshan AF
Cancer Causes Control; 2014 Mar; 25(3):309-19. PubMed ID: 24343304
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of risk factors for breast cancer in Nigerian women.
Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
Int J Cancer; 2006 Nov; 119(9):2179-85. PubMed ID: 16823837
[TBL] [Abstract][Full Text] [Related]
5. A matched case-control study of bean intake and breast cancer risk in urbanized Nigerian women.
Bigman G; Adebamowo SN; Yawe KT; Yilkudi M; Olaomi O; Badejo O; Famooto A; Ezeome E; Salu IK; Miner E; Anosike I; Achusi B; Adebamowo C
Cancer Causes Control; 2022 Jul; 33(7):959-969. PubMed ID: 35511324
[TBL] [Abstract][Full Text] [Related]
6. Determinants of stage at diagnosis of breast cancer in Nigerian women: sociodemographic, breast cancer awareness, health care access and clinical factors.
Jedy-Agba E; McCormack V; Olaomi O; Badejo W; Yilkudi M; Yawe T; Ezeome E; Salu I; Miner E; Anosike I; Adebamowo SN; Achusi B; Dos-Santos-Silva I; Adebamowo C
Cancer Causes Control; 2017 Jul; 28(7):685-697. PubMed ID: 28447308
[TBL] [Abstract][Full Text] [Related]
7. Anthropometry and breast cancer risk in Nigerian women.
Okobia MN; Bunker CH; Zmuda JM; Osime U; Ezeome ER; Anyanwu SN; Uche EE; Ojukwu J; Kuller LH
Breast J; 2006; 12(5):462-6. PubMed ID: 16958966
[TBL] [Abstract][Full Text] [Related]
8. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
Johnson KC; Houseman EA; King JE; Christensen BC
Breast Cancer Res; 2017 Jul; 19(1):81. PubMed ID: 28693600
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of the data collection process for a multicenter, population-based, case-control design.
Wingo PA; Ory HW; Layde PM; Lee NC
Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study.
Dumeaux V; Børresen-Dale AL; Frantzen JO; Kumle M; Kristensen VN; Lund E
Breast Cancer Res; 2008; 10(1):R13. PubMed ID: 18271962
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of comorbidities in women with and without breast cancer in Soweto, South Africa: Results from the SABC study.
Ayeni OA; Joffe M; Cubasch H; Rinaldi S; Taljaard C; Vorster E; Romieu I; Norris SA
S Afr Med J; 2019 Mar; 109(4):264-271. PubMed ID: 31084693
[TBL] [Abstract][Full Text] [Related]
12. Obesity and height in urban Nigerian women with breast cancer.
Adebamowo CA; Ogundiran TO; Adenipekun AA; Oyesegun RA; Campbell OB; Akang EU; Rotimi CN; Olopade OI
Ann Epidemiol; 2003 Jul; 13(6):455-61. PubMed ID: 12875805
[TBL] [Abstract][Full Text] [Related]
13. Case-control study of risk factors for breast cancer in Nigerian women: a pilot study.
Okobia MN; Bunker CH; Lee LL; Osime U; Uche EE
East Afr Med J; 2005 Jan; 82(1):14-9. PubMed ID: 16122106
[TBL] [Abstract][Full Text] [Related]
14. Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.
Okobia MN; Bunker CH; Garte SJ; Zmuda JM; Ezeome ER; Anyanwu SN; Uche EE; Kuller LH; Ferrell RE; Taioli E
BMC Cancer; 2008 Nov; 8():338. PubMed ID: 19017403
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.
Brooks JD; Cairns P; Shore RE; Klein CB; Wirgin I; Afanasyeva Y; Zeleniuch-Jacquotte A
Cancer Epidemiol; 2010 Dec; 34(6):717-23. PubMed ID: 20627767
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.
Adedokun B; Zheng Y; Ndom P; Gakwaya A; Makumbi T; Zhou AY; Yoshimatsu TF; Rodriguez A; Madduri RK; Foster IT; Sallam A; Olopade OI; Huo D
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):359-367. PubMed ID: 31871109
[TBL] [Abstract][Full Text] [Related]
17. Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women.
Kuchiba A; Iwasaki M; Ono H; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Tsugane S; Yoshida T
Br J Cancer; 2014 May; 110(11):2765-71. PubMed ID: 24786600
[TBL] [Abstract][Full Text] [Related]
18. DNA promoter hypermethylation profiles in breast duct fluid.
Twelves D; Nerurkar A; Osin P; Dexter T; Ward A; Gui GP; Isacke CM
Breast Cancer Res Treat; 2013 Jun; 139(2):341-50. PubMed ID: 23674191
[TBL] [Abstract][Full Text] [Related]
19. Socio-economic status and the risk of breast cancer among Nigerian women: a case control study.
Azubuike SO; Hayes L; Sharp L; Alabi A; Oyesegun R; McNally R
Pan Afr Med J; 2022; 41():175. PubMed ID: 35573425
[TBL] [Abstract][Full Text] [Related]
20. Physical activity and the risk of breast cancer among Nigerian women.
Azubuike SO; Hayes L; Sharp L; Alabi A; Oyesegun RA; McNally R
Cancer Epidemiol; 2022 Jun; 78():102163. PubMed ID: 35462345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
